`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________
`MYLAN PHARMACEUTICALS INC.
`Petitioner,
`v.
`BIOGEN MA INC.,
`Patent Owner.
`____________________________________________
`IPR2018-01403
`U.S. Patent No. 8,399,514
`____________________________________________
`
`PATENT OWNER’S AMENDED MANDATORY NOTICES
`
`
`
`
`
`
`Patent Owner’s Mandatory Notices
`Case No. IPR2018-01403
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owner Biogen MA Inc. provides
`
`
`
`the following updated mandatory notices.
`
`Patent Owner has updated Section III Lead and Back-up Counsel to reflect
`
`the addition of Cora R. Holt as back-up counsel.
`
`Patent Owner makes no other changes to the remaining Sections I, II, IV, and
`
`V originally provided on August 2, 2018.
`
`I.
`
`Real Party-in-Interest - 37 C.F.R. § 42.8(b)(1)
`The real party-in-interest is Biogen MA Inc., the owner of U.S. Patent No.
`
`8,399,514 (“the ’514 patent”). A corporate name change document was recorded in
`
`the U.S. Patent and Trademark Office on April 27, 2015 (reel 035507/frame 0541)
`
`and May 4, 2015 (reel 035571/frame 0926). Those documents changed the corporate
`
`name from Biogen Idec MA Inc. to Biogen MA Inc. The original assignment to
`
`Biogen Idec MA Inc. of U.S. patent application No. 13/372,426 that led to the ’514
`
`patent was recorded in the Office on May 3, 2012 (reel 028146/frame 0980).
`
`2
`
`
`
`Patent Owner’s Mandatory Notices
`Case No. IPR2018-01403
`
`
`II. Related Matters - 37 C.F.R. § 42.8(b)(2)
`The ’514 patent is currently involved in the following federal cases:
`
`Biogen International GmbH and Biogen MA Inc. v. Amneal Pharmaceuticals
`LLC et al., C.A. No. 17-823-LPS (D. Del.) (Consolidated)
`
`
`Biogen International GmbH and Biogen MA Inc. v. Mylan Pharmaceuticals
`Inc., C.A. No. 17-116-IMK (N.D. W.Va.)
`
`
`The ’514 patent is currently involved in the follow proceeding before the
`
`PTAB:
`
`Sawai USA Inc. and Sawai Pharmaceutical Co. Ltd. v. Biogen MA Inc., IPR2019-
`
`00789.
`
`The ’514 patent has also been involved in the following proceedings before
`
`the PTAB:
`
`Coalition for Affordable Drugs V LLC v. Biogen MA Inc., IPR2015-01136 (McK)
`
`Coalition for Affordable Drugs V LLC v. Biogen MA Inc., IPR2015-01993 (RES)
`
`Biogen MA Inc. v. Forward Pharma A/S, Intf. No. 106,023 (RES), aff’d, No. 2017-
`
`2109 (Fed. Cir. Oct. 24, 2018), reh’g denied, No. 2017-2109 (January 2, 2019)
`
`The following U.S. Applications claim benefit of priority to the application
`
`that issued as the ’514 patent: 13/767,014 (abandoned), 13/804,283 (abandoned),
`
`14/718,962 (abandoned), 15/959,651 (abandoned), 15/983,837 (abandoned),
`
`15/988,578 (abandoned), 16/221,172 (pending) and 16/238,724 (pending).
`
`3
`
`
`
`Patent Owner’s Mandatory Notices
`Case No. IPR2018-01403
`
`Patent Owner is not aware of any other related matters that would affect or be
`
`
`
`affected by this proceeding.
`
`III. Lead and Back-up Counsel - 37 C.F.R. § 42.8(b)(3)
`
`Lead Counsel
`Barbara C. McCurdy
`Reg. No. 32,120
`Finnegan, Henderson, Farabow, Garrett
`& Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001
`(202) 408-4047
`barbara.mccurdy@finnegan.com
`
`Back-Up Counsel
`Mark J. Feldstein
`Reg. No. 46,693
`Finnegan, Henderson, Farabow, Garrett
`& Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001
`(202) 408-4092
`mark.feldstein@finnegan.com
`
`Erin M. Sommers
`Reg. No. 60,974
`Finnegan, Henderson, Farabow, Garrett
`& Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001
`(202) 408-4292
`erin.sommers@finnegan.com
`
`Pier D. DeRoo
`Reg. No. 69,340
`Finnegan, Henderson, Farabow, Garrett
`& Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001
`(202) 408-4418
`pier.deroo@finnegan.com
`
`Cora R. Holt
`Reg. No. 68,332
`Finnegan, Henderson, Farabow, Garrett
`& Dunner, LLP
`
`4
`
`
`
`Patent Owner’s Mandatory Notices
`Case No. IPR2018-01403
`
`
`
`901 New York Avenue, NW
`Washington, DC 20001
`(202) 408-4334
`cora.holt@finnegan.com
`
`IV. Power of Attorney - 37 C.F.R. § 42.10(b)
`Pursuant to 37 C.F.R. § 42.10(b), Patent Owner confirms that a power of
`
`attorney for U.S. Application No. 13/372,426 (issued as the ’514 patent) from
`
`Biogen MA Inc. to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
`
`(Customer Number 22,852), which includes Barbara C. McCurdy, Erin M.
`
`Sommers, Mark J. Feldstein, Pier D. DeRoo, and Cora R. Holt was previously filed
`
`with the USPTO on April 27, 2015 in Interference No. 106,023. A copy was
`
`attached as Appendix A to Patent Owner’s initial Mandatory Notices filed on August
`
`2, 2018.
`
`V.
`
`Service Information
`Please send all correspondence to the lead counsel at the address shown above.
`
`Under 37 C.F.R. § 42.6(e), Patent Owner consents to electronic service by e-mail to
`
`the following e-mail addresses:
`
`barbara.mccurdy@finnegan.com;
`
`erin.sommers@finnegan.com;
`
`mark.feldstein@finnegan.com;
`
`pier.deroo@finnegan.com, and
`
`5
`
`
`
`cora.holt@finnegan.com.
`
`
`
`
`
`
`Dated: July 9, 2019
`
`Patent Owner’s Mandatory Notices
`Case No. IPR2018-01403
`
`
`
`Respectfully submitted,
`
`
`
`By: / Barbara C. McCurdy /
`Barbara C. McCurdy, Reg. No. 32,120
`Finnegan, Henderson, Farabow, Garrett
` & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`(202) 408-4047
`Counsel for Patent Owner
`
`6
`
`
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that a copy of the foregoing Patent Owner’s
`
`Amended Mandatory Notices was served electronically via e-mail on July 9, 2019,
`
`in its entirety on the following:
`
`Brandon M. White
`Perkins Coie LLP
`700 13th St., NW, Suite 600
`Washington, D.C. 20005
`Telephone: (202) 654-6206
`E-mail: bmwhite@perkinscoie.com
`
`David L. Anstaett
`Emily Greb
`Perkins Coie LLP
`One East Main St., Suite 201
`Madison, WI 53703
`Telephone: (608) 663-7494
`E-mail: danstaett@perkinscoie.com
`E-mail: egreb@perkinscoie.com
`
`Petitioner has agreed to electronic service.
`
`Dated: July 9, 2019
`
`By: / Catherine A. Sadler /
`Catherine A. Sadler
`Case Manager
`
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
